Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Els Verhoeyen

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Cell Reports|June 9, 2023
Distinct subsets of multi-lymphoid progenitors support ontogeny-related changes in human lymphopoiesisSeydou Keita, Samuel Diop, Shalva Lekiashvili, et al.
Plos One|June 20, 2014
High levels of SOX5 decrease proliferative capacity of human B cells, but permit plasmablast differentiationMirzokhid Rakhmanov, Heiko Sic, Anne-Kathrin Kienzler, et al.
The Journal of Experimental Medicine|August 20, 2014
RUNX1-dependent RAG1 deposition instigates human TCR-δ locus rearrangementAgata Cieslak, Sandrine Le Noir, Amélie Trinquand, et al.
Molecular Therapy. Nucleic Acids|July 12, 2023
Nanoblades allow high-level genome editing in murine and human organoidsVictor Tiroille, Adrien Krug, Emma Bokobza, et al.
Cell|July 27, 2010
TRF2 and apollo cooperate with topoisomerase 2alpha to protect human telomeres from replicative damageJing Ye, Christelle Lenain, Serge Bauwens, et al.
Cancer Cell|April 21, 2012
TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expressionSaïda Dadi, Sandrine Le Noir, Dominique Payet-Bornet, et al.
The Journal of Experimental Medicine|August 30, 2024
RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activationAnne Doye, Paul Chaintreuil, Chantal Lagresle-Peyrou, et al.
Cancer Discovery|June 30, 2016
Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell LeukemiaAmélie Trinquand, Nuno R Dos Santos, Christine Tran Quang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 5, 2021
Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editingFriederike Knipping, Gregory A Newby, Cindy R Eide, et al.
Journal of Molecular Cell Biology|October 14, 2015
Atad2 is a generalist facilitator of chromatin dynamics in embryonic stem cellsYuichi Morozumi, Fayçal Boussouar, Minjia Tan, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Cell Reports|June 9, 2023
Distinct subsets of multi-lymphoid progenitors support ontogeny-related changes in human lymphopoiesisSeydou Keita, Samuel Diop, Shalva Lekiashvili, et al.
Plos One|June 20, 2014
High levels of SOX5 decrease proliferative capacity of human B cells, but permit plasmablast differentiationMirzokhid Rakhmanov, Heiko Sic, Anne-Kathrin Kienzler, et al.
The Journal of Experimental Medicine|August 20, 2014
RUNX1-dependent RAG1 deposition instigates human TCR-δ locus rearrangementAgata Cieslak, Sandrine Le Noir, Amélie Trinquand, et al.
Molecular Therapy. Nucleic Acids|July 12, 2023
Nanoblades allow high-level genome editing in murine and human organoidsVictor Tiroille, Adrien Krug, Emma Bokobza, et al.
Cell|July 27, 2010
TRF2 and apollo cooperate with topoisomerase 2alpha to protect human telomeres from replicative damageJing Ye, Christelle Lenain, Serge Bauwens, et al.
Cancer Cell|April 21, 2012
TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expressionSaïda Dadi, Sandrine Le Noir, Dominique Payet-Bornet, et al.
The Journal of Experimental Medicine|August 30, 2024
RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activationAnne Doye, Paul Chaintreuil, Chantal Lagresle-Peyrou, et al.
Cancer Discovery|June 30, 2016
Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell LeukemiaAmélie Trinquand, Nuno R Dos Santos, Christine Tran Quang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 5, 2021
Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editingFriederike Knipping, Gregory A Newby, Cindy R Eide, et al.
Journal of Molecular Cell Biology|October 14, 2015
Atad2 is a generalist facilitator of chromatin dynamics in embryonic stem cellsYuichi Morozumi, Fayçal Boussouar, Minjia Tan, et al.
Pageof 12